The FDA's new rule restricting the sale of compounded semaglutide could make it more difficult for some people to obtain affordable weight loss medications. Here, two people who've relied on compounded GLP-1 drugs share their stories.
| | Sponsored by |  |  | | | | | | | | | | | | | We talked to your gut - it thinks you need this newsletter in you life. | | | | | | | | | | | | | | | | Until then, |  | Take care of yourself, and we'll
see you again soon! | | | | View in browser
Did a friend send you this email? Subscribe here.
To see all newsletters, click here.
Privacy | Unsubscribe
Our website services, content, and products are for informational purposes only. Healthline does not provide medical advice, diagnosis, or treatment and should not be used as a substitute for medical advice from a healthcare professional. Healthline encourages you to make any treatment decisions with your healthcare professional. Healthline is owned by RVO Health.
© 2025 RVO Health
1101 Red Ventures Drive
Fort Mill, SC 29707 | | | |
|
No comments:
Post a Comment